Literature DB >> 27246628

Pancreatic cancer: yesterday, today and tomorrow.

Daniel Ansari1, Bobby Tingstedt1, Bodil Andersson1, Fredrik Holmquist2, Christian Sturesson1, Caroline Williamsson1, Agata Sasor3, David Borg4, Monika Bauden1, Roland Andersson1.   

Abstract

Pancreatic cancer is one of our most lethal malignancies. Despite substantial improvements in the survival rates for other major cancer forms, pancreatic cancer survival rates have remained relatively unchanged since the 1960s. Pancreatic cancer is usually detected at an advanced stage and most treatment regimens are ineffective, contributing to the poor overall prognosis. Herein, we review the current understanding of pancreatic cancer, focusing on central aspects of disease management from radiology, surgery and pathology to oncology.

Entities:  

Keywords:  diagnosis; outcome; pancreatic cancer; treatment

Mesh：

Year:  2016        PMID： 27246628     DOI： 10.2217/fon-2016-0010

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


  89 in total

Review 1.  Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.

Authors:  Ajaykumar C Morani; Abdelrahman K Hanafy; Nisha S Ramani; Venkata S Katabathina; Sireesha Yedururi; Anil K Dasyam; Srinivasa R Prasad
Journal:  Radiol Imaging Cancer       Date:  2020-03-13

2.  Decreased NSG3 enhances PD-L1 expression by Erk1/2 pathway to promote pancreatic cancer progress.

Authors:  Xigang Xia; Ran Li; Peng Zhou; Zhixiang Xing; Chao Lu; Zhida Long; Feiyang Wang; Rui Wang
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

3.  Ultrasound-targeted microbubble destruction-mediated silencing of FBXO11 suppresses development of pancreatic cancer.

Authors:  Jing Xue; Shengjiang Chen; Dongfeng Ge; Xiaozhi Yuan
Journal:  Hum Cell       Date:  2022-04-18       Impact factor: 4.174

4.  Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer.

Authors:  Chen Zhang; Haoran Li; Yujie Huang; Yuchen Tang; Jie Wang; Yinxiang Cheng; Yijun Wei; Dongming Zhu; Zhifei Cao; Jian Zhou
Journal:  J Gastrointest Oncol       Date:  2021-08

Review 5.  Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon.

Authors:  Anna La Salvia; Irene Persano; Elena Parlagreco; Alessandro Audisio; Massimiliano Cani; Maria Pia Brizzi
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

Review 6.  Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review.

Authors:  Qun Chen; Wu-Jun Wang; Yun-Xuan Jia; Hao Yuan; Peng-Fei Wu; Wan-Li Ge; Ling-Dong Meng; Xu-Min Huang; Peng Shen; Tao-Yue Yang; Yi Miao; Jing-Jing Zhang; Kui-Rong Jiang
Journal:  Cell Biosci       Date:  2021-05-13       Impact factor: 7.133

7.  Study of the Mechanism by Which Curcumin Cooperates with Sestrin2 to Inhibit the Growth of Pancreatic Cancer.

Authors:  Haotian Fu; Xiaofeng Ni; Fubiao Ni; Ding Li; Hongwei Sun; Hongru Kong; Yunfeng Shan; Shengjie Dai
Journal:  Gastroenterol Res Pract       Date:  2021-06-30       Impact factor: 2.260

8.  Pancreatic cancer drug-sensitivity predicted by synergy of p53-Activator Wnt Inhibitor-2 (PAWI-2) and protein biomarker expression.

Authors:  Jiongjia Cheng; John R Cashman
Journal:  Invest New Drugs       Date:  2020-09-11       Impact factor: 3.850

9.  LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis.

Authors:  Jing Lin; Shasha Liao; Zewa Liu; E Li; Xiaohua Wu; Wanting Zeng
Journal:  Cancer Biol Ther       Date:  2021-04-02       Impact factor: 4.742

10.  Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.

Authors:  Cheng Hang; Chen Gong; Yanfei Fang; Long Chen; Jianxin Zhu
Journal:  J Mol Histol       Date:  2021-01-04       Impact factor: 2.611
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.